
11 - 50 employees
Founded 2010
🧬 Biotechnology
⚕️ Healthcare Insurance
💊 Pharmaceuticals
💰 $120M Series E on 2022-11
Biotechnology • Healthcare Insurance • Pharmaceuticals
CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing innovative oncolytic immunotherapies for patients with bladder cancer. The company's primary investigational product, cretostimogene grenadenorepvec, aims to provide a bladder-sparing therapeutic option, enhancing the quality of life for afflicted patients. With ongoing clinical studies highlighting the potential benefits of their therapies, CG Oncology strives to address the unmet needs in bladder cancer treatment.
🔥 13 hours ago
Improve your chances of getting an interview by checking your resume score before you apply.

11 - 50 employees
Founded 2010
🧬 Biotechnology
⚕️ Healthcare Insurance
💊 Pharmaceuticals
💰 $120M Series E on 2022-11
Biotechnology • Healthcare Insurance • Pharmaceuticals
CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing innovative oncolytic immunotherapies for patients with bladder cancer. The company's primary investigational product, cretostimogene grenadenorepvec, aims to provide a bladder-sparing therapeutic option, enhancing the quality of life for afflicted patients. With ongoing clinical studies highlighting the potential benefits of their therapies, CG Oncology strives to address the unmet needs in bladder cancer treatment.
• Develop and execute Private Equity/IDNs/ Top LUGPAs Strategic Account Plans, establish engagement points and actions with appropriate stakeholders to map organizations interests and hierarchy. • Remove barriers within Private Equity/IDNs/Large LUGPAs/VA/DoD to drive demand • Facilitates strategic engagement between CG Oncology ELT/Senior stakeholders and key Private Equity/IDNs/Large LUGPAs/VA/DoD stakeholders • Manage large geographies, identify opportunities and evolving trends across Private Equity/IDNs/Large LUGPAs/VA/DoD that are consistent with the goals of the YOLO Launch Strategic Imperatives • Align Private Equity/IDNs/Large LUGPAs/VA/DoD with Local Market Strategy & Leadership • Bridge alignment between the Health Systems Director and other field functions • Long Term Strategic Focus and align the goals of the PEs/IDNs/Large LUGPAs with the goals of CG Oncology • Lead, mobilize, and establish standing pull through and strategic account planning market meetings with market stakeholders • Routinely communicate ongoing success, opportunities and identify new, unique and profitable business opportunities • Ensure collaboration and partnership with field leadership, market access, marketing and operations to ensure best in class launch • Inform the organization of trends and market insights, risks, opportunities for success etc. • Inform and influence key opinion leaders (KOLs) • Develop customer specific strategies, roadmap, segmentation, and account plans for all targeted accounts • Build and maintain strong long-term customer relationships/partnerships that drive key initiatives related to our growth and success • Collaborate with field teams (KAMs, FRM’s, Market Access, Medical Affairs, etc..) to monitor the market landscape to identify key trends, barriers, and partner with colleagues to mitigate.
• Bachelor's Degree in related field • Twelve (10) years of proven commercial experience within the biopharmaceutical industry with a minimum of 5 years of documented success with IDNs, payers, key sites of care, healthcare, private equity organizations, large group accounts, and/or national /regional hospital systems. • Minimum 5 years Uro-Oncology, Urology, or specialty sales position • MBA or other advanced degree preferred. • Deep knowledge and proven success in hospital sales and national / regional systems preferred. • Thorough understanding hospital systems, large group practices, medical policies, pathway and protocols, and buy and bill process required. • Strong understanding of health system decision making. • Documented access to appropriate stakeholders in targeted accounts preferred. • Experience or proven ability to negotiate with, and sell to, top senior decision makers preferred. • Demonstrated success in building and maintaining direct relationships with key payers, IDNs and stakeholders, as well as establishing patient and HCP pull-through support programs. • Proven ability to define and articulate product value propositions.
• HIGHLY COMPETITIVE SALARIES • ANNUAL PERFORMANCE/MERIT REVIEWS • ANNUAL PERFORMANCE BONUSES • EQUITY • SPECIAL RECOGNITION • FULLY REMOTE WORK ENVIRONMENT • REST AND RECHARGE BENEFITS - Unlimited Flexible Time Off • HOLIDAYS – In 2026 we will observe 14 holidays • RETIREMENT – 401K with 100% company Safe Harbor match up to 4% of base salary • HEALTH (MEDICAL, DENTAL, VISION) – PPO & HDHP – Cigna/Principal • HEALTH SPENDING ACCOUNTS - HSA (with Annual Company Contribution), FSA, FSA-DC • ILLNESS & DISABILITY PROTECTION – Company Paid LTD Coverage + Voluntary Plans • LIFE INSURANCE – Company Paid 1 x base salary + Voluntary Plans • ADDITIONAL EXCLUSIVE BENEFITS – Voluntary Legal, Pet, Plus More
Apply Now🔥 13 hours ago
Director overseeing Microelectronics Commons program worth $2B at NSTXL. Leading strategic direction and execution in partnership with the US government.
🔥 14 hours ago
Director of Global Trade Compliance & Logistics at C.H. Robinson ensuring customs compliance and risk management. Overseeing global trade operations and collaborating across functions.
🔥 15 hours ago
Director responsible for managing a team in engineering and manufacturing initiatives at CTC. Driving organizational growth and technical innovation for a new U.S. Navy initiative.
🔥 15 hours ago
Director at CTC responsible for leading teams and driving technical innovation. Overseeing projects and workforce development for cutting-edge solutions in engineering and manufacturing.
🔥 15 hours ago
51 - 200
Commercial Director leading private equity due diligence and value creation initiatives at Ducker Carlisle. Responsible for client relationships and project management in the professional services vertical.